Average Co-Inventor Count = 10.52
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (6 from 4,948 patents)
2. Roche Palo Alto LLC (4 from 322 patents)
3. Genmab A+s (3 from 107 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
13 patents:
1. 9187565 - Antibodies against CD38 for treatment of multiple myeloma
2. 9102733 - Anti-OX40L antibodies
3. 9040050 - Combination treatment of CD38-expressing tumors
4. RE44389 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
5. RE44359 - Nucleic acid molecules encoding anti-P-selectin antibodies
6. RE43568 - Anti-P-selectin antibodies
7. 7868141 - Anti-OX40L antibodies
8. 7829673 - Antibodies against CD38 for treatment of multiple myeloma
9. 7824684 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
10. 7807158 - Antibodies against IL-13 receptor alpha1 and uses thereof
11. 7754867 - Nucleic acid molecules encoding anti-P-selectin antibodies
12. 7563441 - Anti-P-selectin antibodies
13. 7501496 - Anti-OX40L antibodies